MRI abnormalities are seen in 81% of cases treated with anti-CTLA-4, whereas in 18% of patients with hypophysitis treated with anti-PD-1/anti-PD-L1, the initial enlargement of the pituitary returns to normal within weeks [27]. This evidence concerns the gene CTLA4 and hypophysitis.